Company news

Acucort Ab (NGM:ACUC) news

Acucort Ab news releases on 6ix. Latest, Sep 16, 2026: AcuCort awarded funding from Region Skåne to support its US expansion

View Acucort Ab →

Press releases & updates

AcuCort awarded funding from Region Skåne to support its US expansion

September 16, 2026

AcuCort's warrant programme fully subscribed - key personnel to become shareholders in the company

September 1, 2026

AcuCort: AcuCort study on patient preferences published in peer-reviewed scientific journal

August 26, 2026

AcuCort: AcuCort appoints Carl Frisk as Strategic Alliance Manager

August 24, 2026

AcuCort : first Phase IV study is now published

August 11, 2026

AcuCort: AcuCort’s first Phase IV study is now published

August 11, 2026

AcuCort : granted renewed FDA Small Business Waiver – Important milestone ahead of planned NDA submission in 2026

July 27, 2026

AcuCort: AcuCort granted renewed FDA Small Business Waiver – Important milestone ahead of planned NDA submission in 2026

July 27, 2026

AcuCort: AcuCort publishes newsletter with CEO update

June 17, 2026

AcuCort: AcuCort to attend BIO International Convention in San Diego – focus on strategic partnering discussions

June 11, 2026

AcuCort : to attend BIO International Convention in San Diego – focus on strategic partnering discussions

June 11, 2026

AcuCort : publishes newsletter with CEO update

April 16, 2026

AcuCort: AcuCort and the FDA agree on iPSP – important step towards US market approval

April 13, 2026

AcuCort and the FDA agree on iPSP - important step towards US market approval

April 13, 2026

AcuCort: AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries

January 22, 2026

AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries

January 22, 2026

AcuCort : Secures New Order for Zeqmelit® – Continued Growth Across the Nordics

December 8, 2025

AcuCort: AcuCort Secures New Order for Zeqmelit® – Continued Growth Across the Nordics

December 8, 2025

AcuCort Secures New Order for Zeqmelit® - Continued Growth Across the Nordics

December 8, 2025

AcuCort: AcuCort strengthens its management team with the appointment of Anna Chérouvrier Hansson as Business Development Director

October 14, 2025

AcuCort: AcuCort granted extended SME status by the European Medicines Agency (EMA)

September 25, 2025

AcuCort granted extended SME status by the European Medicines Agency (EMA)

September 25, 2025

AcuCort: AcuCort’s CEO to present at Life Science Conference in Copenhagen

September 18, 2025

AcuCort: Sales of Zeqmelit® commenced in Denmark

August 12, 2025